Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 511 AL 525

Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders

Ruszkiewicz J, Albrecht J.

Neurochem Int. 2015 Sep;88:66-72. doi: 10.1016/j.neuint.2014.12.012. Epub 2015 Jan 6.

Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence

Mattson MP.

Ageing Res Rev. 2015 Mar;20:37-45. doi: 10.1016/j.arr.2014.12.011. Epub 2015 Jan 7.

Postencephalitic parkinsonism and selective involvement of substantia nigra

He S, Yuan LP, Zhang JW, Han X.

Neurol Sci. 2015 Apr;36(4):653-5. doi: 10.1007/s10072-015-2064-x. Epub 2015 Jan 11.

Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis

Chen Y, Li S, Su L, Sheng J, Lv W, Chen G, Xu Z.

J Neurol. 2015;262(4):814-22. doi: 10.1007/s00415-014-7630-2. Epub 2015 Jan 13.

Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias

Stathis P, Konitsiotis S, Antonini A.

Expert Rev Neurother. 2015 Feb;15(2):207-13. doi: 10.1586/14737175.2015.1001747. Epub 2015 Jan 12.

Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study

Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.

Clin Neuropharmacol. 2015 Jan-Feb;38(1):23-5. doi: 10.1097/WNF.0000000000000061.

Chronic traumatic encephalopathy: historical origins and current perspective

Montenigro PH, Corp DT, Stein TD, Cantu RC, Stern RA.

Annu Rev Clin Psychol. 2015;11:309-30. doi: 10.1146/annurev-clinpsy-032814-112814. Epub 2015 Jan 12.

Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging

Ren R, Sun Y, Zhao X, Pu X.

Clin Chem Lab Med. 2015 Sep 1;53(10):1495-506. doi: 10.1515/cclm-2014-0783.

Axial disability and deep brain stimulation in patients with Parkinson disease

Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR.

Nat Rev Neurol. 2015 Feb;11(2):98-110. doi: 10.1038/nrneurol.2014.252. Epub 2015 Jan 13.

Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease

Zlatic S, Comstra HS, Gokhale A, Petris MJ, Faundez V.

Neurobiol Dis. 2015 Sep;81:154-61. doi: 10.1016/j.nbd.2014.12.024. Epub 2015 Jan 10.

[Identification of paroxysmal, transient arrhythmias: Intermittent registration more efficient than the 24-hour Holter monitoring]

Hendrikx T, Rosenqvist M, Sandström H, Persson M, Hörnsten R.

Lakartidningen. 2015 Jan 6;112:C6SE.

[Parkinson's disease and psychoses]

Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP.

Neuropsychiatr. 2015;29(1):1-13. doi: 10.1007/s40211-014-0132-8. Epub 2015 Jan 14.

An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease

Zhang Z, Wang J, Zhang X, Chen S, Wang Z, Zhang B, Liu C, Qu Q, Cheng Y, Zhu R, Li J, Hu J, Cai M.

Curr Med Res Opin. 2015 Apr;31(4):723-30. doi: 10.1185/03007995.2015.1005835. Epub 2015 Mar 12.

MS-based methods for biomarkers of Parkinson's disease: what is the future?

Barkovits K, Helling S, Marcus K.

Bioanalysis. 2015;7(2):149-51. doi: 10.4155/bio.14.273.

Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients

Slevin JT, Fernandez HH, Zadikoff C, Hall C, Eaton S, Dubow J, Chatamra K, Benesh J.

J Parkinsons Dis. 2015;5(1):165-74. doi: 10.3233/JPD-140456.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias